HOOKIPA Pharma Q2 EPS $(0.22) Misses $(0.21) Estimate, Sales $2.68M Miss $4.87M Estimate
Portfolio Pulse from Benzinga Newsdesk
HOOKIPA Pharma (NASDAQ:HOOK) reported Q2 losses of $(0.22) per share, missing the analyst consensus estimate of $(0.21) by 4.76%. The company also reported quarterly sales of $2.68 million, missing the analyst consensus estimate of $4.87 million by 44.99%. This represents a 2.44% decrease over sales from the same period last year.
August 10, 2023 | 11:05 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
HOOKIPA Pharma's Q2 earnings and sales missed analyst estimates, which could negatively impact the stock price in the short term.
HOOKIPA Pharma's Q2 earnings and sales fell short of analyst estimates. This underperformance could lead to a decrease in investor confidence and a potential drop in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100